Abstract Aims/hypothesis The Islet Autoantibody Standardization Program (IASP) aims to
improve the performance of immunoassays measuring autoantibodies in type 1 diabetes …

Background The incidence of type 1 diabetes mellitus (T1DM) in children is increasing,
resulting in higher burden of cardiovascular diseases due to diabetes mellitus–related …

OBJECTIVE β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes.
Here, we asked how frequently they revert in a cohort of children at risk for type 1 diabetes …

Objectives To describe the characteristics of children and adults with incident type 1
diabetes in contemporary, multiethnic UK, focusing on differences between the islet …

Using global liquid chromatography-mass spectrometry (LC-MS)–based proteomics
analyses, we identified 24 serum proteins that were significantly variant between those with …

Type 1 diabetes mellitus (T1DM) is the archetypal example of a T cell‐mediated
autoimmune disease characterized by selective destruction of pancreatic β cells. The …

Harmonization of biomarkers is important for the comparability of laboratory results as it
allows the definition of universal reference values and clinical decision limits. In diabetology …

Type 1 diabetes mellitus (T1D) is an autoimmune disease encompassing the T-cell-
mediated destruction of pancreatic β cells and the production of autoantibodies against islet …

Type 1 diabetes mellitus (T1DM) is an autoimmune disorder directed against the β cells of
the pancreatic islets. The genetic risk of the disease is linked to HLA-DQ risk alleles and …

OBJECTIVE To examine duration of breastfeeding and timing of complementary foods and
risk of islet autoimmunity (IA). RESEARCH DESIGN AND METHODS The Environmental …